Sign in to CMS Desk. Sign in to CMS Site Manager. The default account is administrator with blank password.
Services > Womens Health > Gynecologic Pathology

Gynecologic Pathology

Our two fellowship trained sub-specialists in Gynecologic Pathology provide a broad range of services to physicians and their patients, including diagnosis and staging for patients undergoing surgical treatment of gynecologic cancers, diagnosis of cervical biopsies and correlation with previous pathology and Pap tests, HPV DNA testing, pathologic diagnosis for patients with benign diseases of the genital tract, and pathologic examination of placentas. Our Gynecologic Pathology sub-specialty is led by Dr. Ellen Pizer, and Dr. Christina Isacson.

90% of Surgical cases are diagnosed and reported within 48 hours

Featured Pathologist

Christina Isacson, M.D.
Pathologist - Seattle
Dr. Isacson is a gynecologic pathologist with an interest in teaching and women’s health issues.  She graduated Magna Cum Laude in Biology from Carleton College and completed her Medical Degree at the University of Iowa College ...
View Full Bio

Other Subspecialist Pathologists

Types of Testing We Do

Pathologic diagnosis of biopsies and surgical resections of the female genital tract.

  • HPV DNA testing
  • Testing for Gonorrhea, Trichomonas Vaginalis, Chlamydia and HPV from liquid Pap vial
  • Pap test interpretation from SurePath® and ThinPrep® liquid vials as well as conventional smears

Relevant Conditions

  • Endometrial cancer
  • Cervical cancer
  • Ovarian cancer
  • Fallopian tube cancer
  • Endometriosis
  • Uterine leiomyomas (fibroids)




  • The 2006 Consensus Guidelines for the Management of Women with Abnormal Cervical Cancer Screening Tests:  American Journal of Obstetrics and Gynecology (2007;197(4); 346-355).
  • Statement on HPV DNA test utilization.  Solomon D, Papillo JL, Davey DD; Cytopathology Education and Technology Consortium.  Acta Cytol. 2009 May-Jun;53(3):247-8; discussion 249-52. PMID: 19534262   
  • Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Pecorelli S. Int J Gynaecol Obstet. 2009 May;105(2):103-4. PMID: 19367689   
  • Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction.Callahan MJ, Crum CP, Medeiros F, Kindelberger DW, Elvin JA, Garber JE, Feltmate CM, Berkowitz RS, Muto MG.J Clin Oncol. 2007. 25(25):3985-90. PMID: 17761984   
  • Intercepting early pelvic serous carcinoma by routine pathological examination of the fimbria. Semmel DR, Folkins AK, Hirsch MS, Nucci MR, Crum CP. Mod Pathol. 2009. PMID: 19407856